1. Home
  2. MRUS vs BVN Comparison

MRUS vs BVN Comparison

Compare MRUS & BVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • BVN
  • Stock Information
  • Founded
  • MRUS 2003
  • BVN 1953
  • Country
  • MRUS Netherlands
  • BVN Peru
  • Employees
  • MRUS N/A
  • BVN N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • BVN Metal Mining
  • Sector
  • MRUS Health Care
  • BVN Basic Materials
  • Exchange
  • MRUS Nasdaq
  • BVN Nasdaq
  • Market Cap
  • MRUS 2.7B
  • BVN 3.1B
  • IPO Year
  • MRUS 2016
  • BVN 1996
  • Fundamental
  • Price
  • MRUS $42.77
  • BVN $14.69
  • Analyst Decision
  • MRUS Strong Buy
  • BVN Buy
  • Analyst Count
  • MRUS 14
  • BVN 2
  • Target Price
  • MRUS $87.00
  • BVN $16.75
  • AVG Volume (30 Days)
  • MRUS 786.0K
  • BVN 1.1M
  • Earning Date
  • MRUS 05-07-2025
  • BVN 05-01-2025
  • Dividend Yield
  • MRUS N/A
  • BVN 1.90%
  • EPS Growth
  • MRUS N/A
  • BVN 1928.16
  • EPS
  • MRUS N/A
  • BVN 1.59
  • Revenue
  • MRUS $54,732,000.00
  • BVN $1,154,605,000.00
  • Revenue This Year
  • MRUS $26.81
  • BVN N/A
  • Revenue Next Year
  • MRUS $23.85
  • BVN N/A
  • P/E Ratio
  • MRUS N/A
  • BVN $9.46
  • Revenue Growth
  • MRUS N/A
  • BVN 40.15
  • 52 Week Low
  • MRUS $33.19
  • BVN $11.50
  • 52 Week High
  • MRUS $61.61
  • BVN $18.84
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 49.60
  • BVN 51.46
  • Support Level
  • MRUS $37.92
  • BVN $13.46
  • Resistance Level
  • MRUS $46.36
  • BVN $15.46
  • Average True Range (ATR)
  • MRUS 2.56
  • BVN 0.52
  • MACD
  • MRUS -0.22
  • BVN 0.04
  • Stochastic Oscillator
  • MRUS 57.46
  • BVN 61.55

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About BVN Buenaventura Mining Company Inc.

Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.

Share on Social Networks: